Ling Ding

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Small Cell Lung Cancer

Ejection Fraction

Top Venues

Molecular cancer therapeutics

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for correlations between metabolites in patients receiving immunotherapy for metastatic or recurrent NSCLC: an exploratory study based on two cohorts. Molecular cancer therapeutics (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Ling Ding, Hongjie Guo, Jie Zhang, Mingming Zheng, Wenjie Zhang, Longsheng Wang, Qianqian Du, Chen Zhou, Yanjun Xu, Honghai Wu, Qiaojun He, Bo Yang
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Xiaohui Pan, Wenxin Zhang, Longsheng Wang, Hongjie Guo, Mingming Zheng, Honghai Wu, Qinjie Weng, Qiaojun He, Ling Ding, Bo Yang
KLF12 transcriptionally regulates PD-L1 expression in non-small cell lung cancer. Molecular oncology (2023)